Latest Benign Neoplasms News
FDA Approves Ogsiveo, a Groundbreaking Treatment for Desmoid Tumors
A Game-Changer in the Treatment of Desmoid Tumors The US Food and…
Therapeutic Access and Emerging Treatments
This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild,…
Strategic Desmoid Tumor Education and Access
This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild,…
Multiple Facial Papules | MDedge Dermatology
The Diagnosis: Birt-Hogg-Dubé Syndrome Histopathologic examination revealed a collection of bland spindle…
Teen with rare tumor advocates for mental health awareness
GRAND RAPIDS, MI – A year ago, Gabe Augdahl struggled with not…
Immunome wins Ayala’s Phase III desmoid tumour candidate for $50m
Immunome will pay $20m upfront and $30m in common stock. A further…
NCCN Guidelines and Treatment Insights for Desmoid Tumors
This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild,…
Immunome (IMNM) to Acquire Desmoid Tumor Candidate, Stock Up
Shares of Immunome, Inc. IMNM were up 36.9% on Feb 6 after…
Immunome wins Ayala’s Phase III desmoid tumour candidate for $50m
Immunome will pay $20m upfront and $30m in common stock. A further…